Arena Pharma (ARNA) volatility elevated into FDA review

June 16, 2010 7:49 AM EDT Send to a Friend
Arena Pharmaceuticals (Nasdaq: ARNA) closed at $2.95. The FDA has a tentative scheduling of an Endocrinologic and Metabolic Drugs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login